Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Stereotactic Body Radiation Therapy

Known as: SBRT 
A type of external radiation therapy that uses special equipment to position a patient and precisely deliver radiation to tumors in the body (except… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline.
PURPOSE This guideline presents evidence-based recommendations for stereotactic body radiation therapy (SBRT) in challenging… Expand
Is this relevant?
Review
2017
Review
2017
Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation
BACKGROUND As systemic therapy has improved for locally advanced pancreatic cancer (LAPC), efforts to improve local control with… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma.
PURPOSE To describe outcomes of prospective trials of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC… Expand
  • figure 1
  • table 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
PURPOSE To evaluate the efficacy and tolerability of high-dose stereotactic body radiation therapy (SBRT) for the treatment of… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study.
PURPOSE The 50-month results of a prospective Phase II trial of stereotactic body radiation therapy (SBRT) in medically… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.
PURPOSE To evaluate the efficacy and tolerability of high-dose stereotactic body radiation therapy (SBRT) for the treatment of… Expand
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.
PURPOSE The impact of stereotactic body radiotherapy (SBRT) on 3-year progression-free survival of medically inoperable patients… Expand
Is this relevant?
Review
2007
Review
2007
Stereotactic body radiation therapy in multiple organ sites.
INTRODUCTION Stereotactic body radiation therapy (SBRT) uses advanced technology to deliver a potent ablative dose to deep-seated… Expand
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer.
PURPOSE Surgical resection is standard therapy in stage I non-small-cell lung cancer (NSCLC); however, many patients are… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases.
PURPOSE To determine the maximum tolerated dose (MTD) of stereotactic body radiation therapy (SBRT) for liver metastases… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE